These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Frequent activating GNAS mutations in villous adenoma of the colorectum. Yamada M; Sekine S; Ogawa R; Taniguchi H; Kushima R; Tsuda H; Kanai Y J Pathol; 2012 Sep; 228(1):113-8. PubMed ID: 22374786 [TBL] [Abstract][Full Text] [Related]
3. GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features. Liu C; McKeone DM; Walker NI; Bettington ML; Leggett BA; Whitehall VLJ Histopathology; 2017 Jun; 70(7):1079-1088. PubMed ID: 28164369 [TBL] [Abstract][Full Text] [Related]
4. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952 [TBL] [Abstract][Full Text] [Related]
5. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix. Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192 [TBL] [Abstract][Full Text] [Related]
6. Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum. Matsubara A; Ogawa R; Suzuki H; Oda I; Taniguchi H; Kanai Y; Kushima R; Sekine S Br J Cancer; 2015 Apr; 112(8):1398-404. PubMed ID: 25867268 [TBL] [Abstract][Full Text] [Related]
7. Absence of GNAS mutation in colorectal carcinogenesis. Lee H; La BM; Hwang I; Kang YN; Choi IJ; Lee JH Tumori; 2017 Mar; 103(2):209-211. PubMed ID: 26350188 [TBL] [Abstract][Full Text] [Related]
8. GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas. Ritterhouse LL; Vivero M; Mino-Kenudson M; Sholl LM; Iafrate AJ; Nardi V; Dong F Mod Pathol; 2017 Dec; 30(12):1720-1727. PubMed ID: 28776576 [TBL] [Abstract][Full Text] [Related]
9. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type. Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233 [TBL] [Abstract][Full Text] [Related]
10. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations. Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653 [TBL] [Abstract][Full Text] [Related]
11. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival. Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222 [TBL] [Abstract][Full Text] [Related]
12. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Einspahr JG; Martinez ME; Jiang R; Hsu CH; Rashid A; Bhattacharrya AK; Ahnen DJ; Jacobs ET; Houlihan PS; Webb CR; Alberts DS; Hamilton SR Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1443-50. PubMed ID: 16896030 [TBL] [Abstract][Full Text] [Related]
13. Association of APC gene mutations and histological characteristics of colorectal adenomas. De Benedetti L; Sciallero S; Gismondi V; James R; Bafico A; Biticchi R; Masetti E; Bonelli L; Heouaine A; Picasso M Cancer Res; 1994 Jul; 54(13):3553-6. PubMed ID: 8012980 [TBL] [Abstract][Full Text] [Related]
14. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234 [TBL] [Abstract][Full Text] [Related]
15. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum. Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095 [TBL] [Abstract][Full Text] [Related]
16. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer. Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096 [TBL] [Abstract][Full Text] [Related]
17. GNAS Is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct. Tsai JH; Yuan RH; Chen YL; Liau JY; Jeng YM Am J Surg Pathol; 2013 Dec; 37(12):1862-70. PubMed ID: 24061513 [TBL] [Abstract][Full Text] [Related]
18. Correlation of polypoid colorectal adenocarcinoma with pre-existing adenomatous polyps and KRAS mutation. Chen H; Lefferts JA; Schwab MC; Suriawinata AA; Tsongalis GJ Cancer Genet; 2011 May; 204(5):245-51. PubMed ID: 21665177 [TBL] [Abstract][Full Text] [Related]
20. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component. Kakar S; Deng G; Cun L; Sahai V; Kim YS Hum Pathol; 2008 Jan; 39(1):30-6. PubMed ID: 17950780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]